Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Cash Flows (Unaudited)

v3.10.0.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
6 Months Ended
Jun. 30, 2018
Jun. 30, 2017
Cash flows used in operating activities:    
Net loss from continuing operations $ (101,321,877) $ (18,602,657)
Adjustments to reconcile net income (loss) to net cash used in operations:    
Depreciation and amortization 651,248 846,853
Gain on sale of fixed assets (391,103)
Stock-based compensation 661,286 69,230
Gain on purchase of Jamestown Regional Medical Center (7,732,302)
Non-cash interest expense 7,418,722
Amortization of debt discount 7,072,228 2,498,120
Non-cash settlement of debt (50,000)
Gain on extinguishment of debt (42,702,815)
Change in fair value of derivative instruments 95,616,653 42,702,815
Income (loss) from discontinued operations 275,216 (1,744,209)
Changes in operating assets and liabilities:    
Accounts receivable (1,948,788) 908,269
Inventory (39,689)
Prepaid expenses and other current assets 13,122 (71,845)
Security deposits 5,263 10,441
Accounts payable 637,865 452,327
Accrued expenses 1,519,733 (35,147)
Income tax assets and liabilities (3,363) (346,997)
Net cash used in operating activities of continuing operations (4,984,508) (8,646,898)
Net cash (used in) provided by discontinued operations (772,478) 35,414
Net cash used in operating activities (5,756,986) (8,611,484)
Cash flows provided by (used in) investing activities:    
Purchase of Jamestown Regional Medical Center, net of cash acquired (634,721)
Sale of property and equipment 433,612
Purchase of property and equipment (1,394,087)
Net cash used in investing activities of continuing operations (201,109) (1,394,087)
Net cash provided by investing activities of discontinued operations 800,000 1,936
Net cash provided by (used in) investing activities 598,891 (1,392,151)
Cash flows provided by financing activities:    
Proceeds from issuance of related party notes payable and advances 590,000 3,715,000
Proceeds from issuance of debentures 5,500,000 11,642,500
Payments on related party notes payable and advances (3,550,000)
Payments on notes payable (256,481) (716,998)
Payments on capital lease obligations (668,366) (1,141,166)
Net cash provided by financing activities of continuing operations 5,165,153 9,949,336
Net cash used in financing activities of discontinued operations
Net cash provided by financing activities 5,165,153 9,949,336
Net increase (decrease) in cash 7,058 (54,299)
Cash at beginning of period 70,173
Cash at end of period $ 7,058 $ 15,874